Nostrum Medical Center West Dade LLC is categorized under Medical Centers in Miami, FL and active since 2011.
Nostrum Medical Center West Dade LLC was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number 621112 by the NAICS.
If you are seeking more information, feel free to contact Jose A Esnard at the company’s single location by writing to 4155 Sw 130th Avenue # 103, Miami, Florida FL 33175 or by phoning (305) 223-3580. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Nostrum Medical Center West Dade LLC |
| Contact Person: | Jose A Esnard |
| Address: | 4155 Sw 130th Avenue # 103, Miami, Florida 33175 |
| Phone Number: | (305) 223-3580 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Centers |
| SIC Code: | 8011 |
| NAICS Code: | 621112 |
| Share This Business: |
Nostrum Medical Center West Dade LLC was started in 2011 to provide professional Medical Centers under the SIC code 8011 and NAICS code 621112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jose A Esnard for inquiries that concern Nostrum Medical Center West Dade LLC by calling the company number (305) 223-3580, as your correspondence is most welcome. Additionally, the physical location of the single location of Nostrum Medical Center West Dade LLC can be found at the coordinates 25.729672,-80.405483 as well as the street address 4155 Sw 130th Avenue # 103 in Miami, Florida 33175.
For its online presence, you may visit Nostrum Medical Center West Dade LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.